Ecolab Inc.
Ecolab Inc. is a global leader in water, hygiene, and infection prevention solutions. It provides technologies and services that promote clean, safe, and sustainable environments.

Join Our Programs
Our clients trust us for our expert advice and in-depth market analysis. Discover our services to gain more knowledge on investing.
Stock Market Webinar
Join our Stock Market Webinar to gain clear, actionable insights into current market trends. Learn how to analyse data, interpret signals, and make informed investment decisions with confidence. Designed for both beginners and experienced investors, this session delivers practical knowledge you can apply immediately.

Performance
Ecolab Inc. (NYSE: ECL) reported robust financial performance in 2024, achieving record full-year adjusted diluted earnings per share (EPS) of $6.65, a 28% increase from the previous year. The company’s fourth-quarter adjusted EPS rose 17% year-over-year to $1.81, surpassing analyst expectations, while revenue reached $4 billion. Strong growth in the Institutional & Specialty, Pest Elimination, and Life Sciences segments contributed to a 3% increase in organic sales. Ecolab also delivered record free cash flow of $1.8 billion for the year. Looking ahead, the company forecasts 2025 adjusted EPS between $7.42 and $7.62, representing a 12% to 15% increase, driven by continued demand for its water, hygiene, and infection prevention solutions.
Quality of Earnings
The company demonstrates strong adherence to General Accounting Principles, with financial reports that conform to GAAP, are decision-useful, sustainable, and offer returns exceeding the cost of capital. There have been no recent changes to accounting policies, and all required financial reports are submitted on time. Revenue quality is also robust, marked by high predictability—with a substantial portion of clients returning year after year—strong profitability with gross margins exceeding 70%, diversified income sources with no client accounting for more than 15% of revenue, and clear growth in both revenue and net income. Additionally, there are no significant financial report warning signs: earnings contain minimal accrual components, do not narrowly beat benchmarks in a suspicious pattern, and revenue is not recognized prematurely. Expenses are not misrepresented, audit opinions are unqualified, goodwill is properly assessed, and the company does not rely on aggressive accounting tactics such as related-party transactions or off-balance-sheet debt. Operating ccash flows align with net income, earnings are recurring and persistent, and there is no history of restatements or enforcement actions, reinforcing the reliability and quality of the company’s financial reporting.

Company Summary
Ecolab Inc. (NYSE: ECL) is a global leader in water treatment, hygiene, and infection prevention solutions, serving industries such as food, healthcare, hospitality, and manufacturing across more than 170 countries.
